CannPal progressing canine cannabinoid trials.  (Phase 2A pilot dose determination study for canine osteoarthritis and DermaCann trial starting soon.) For more information:


Penn Vet to study hemp-based supplement. For more information:


Canopy Growth announces clinical trial approval for the use of cannabis to treat anxiety in certain animals.  For more information:

CannPal Animal Therapeutics commences Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived pain control for dogs.  For more information:


For a handy chart of just some of the many studies currently underway in the US, refer to the article in AAHA Trends magazine titled:

"How Expanded Research Is Clearing Up Cannabis Confusion"  by Sarah  Rumple